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MitoQReactive oxygen species (ROS) are formed upon incomplete reduction of molecular oxygen (O2) as an
inevitable consequence of mitochondrial metabolism. Because ROS can damage biomolecules, cells contain
elaborate antioxidant defense systems to prevent oxidative stress. In addition to their damaging effect, ROS
can also operate as intracellular signaling molecules. Given the fact that mitochondrial ROS appear to be only
generated at speciﬁc sites and that particular ROS species display a unique chemistry and have speciﬁc
molecular targets, mitochondria-derived ROS might constitute local regulatory signals. The latter would
allow individual mitochondria to auto-regulate their metabolism, shape and motility, enabling them to
respond autonomously to the metabolic requirements of the cell. In this review we ﬁrst summarize how
mitochondrial ROS can be generated and removed in the living cell. Then we discuss experimental strategies
for (local) detection of ROS by combining chemical or proteinaceous reporter molecules with quantitative
live cell microscopy. Finally, approaches involving targeted pro- and antioxidants are presented, which allow
the local manipulation of ROS levels.ase;MIM,mitochondrial inner
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Reactive oxygen species (ROS) are partially reduced derivatives of
molecular oxygen (O2) that can react with many cellular constituents
including lipids, proteins and DNA. Depending on the type of cell and
its metabolic state, mitochondria can represent a substantial source of
ROS within healthy living cells as an unavoidable consequence of
metabolism. Important sources of mitochondrial ROS include complex
I (CI) of the electron transport chain (ETC) and the tricarboxylic
acid (TCA) cycle enzyme α-ketoglutarate dehydrogenase (α-KGDH)
[1,2]. Both CI- and α-KGDH generate ROS in the form of superoxide
(O2•−), which can be subsequently converted into other ROS including
hydrogen peroxide (H2O2). Oxidative stress occurs when mitochon-
drial ROS production exceeds the capacity of the cell's antioxidant
systems. In addition to this toxic role, when produced at low levelsmitochondrial ROS and its downstream products might also operate
as intracellular signaling molecules [3–8]. A signaling function is
already well established for reactive nitrogen species (RNS) like nitric
oxide as reviewed elsewhere (e.g. [9]). Up to now, ROS-dependent
signaling has mainly been studied using exogenous ROS generating
systems that increase ROS throughout the cell (‘global’ ROS).
However, when produced within living cells the lifetime of a certain
ROS limits the distance it can diffuse and thereby its radius of action.
This means that the direct reaction of a short-lived ROS like O2•− in
situ is likely restricted to a small sub-cellular volume surrounding the
site of its generation (‘local’ ROS) whereas ROS with a longer half-life
like H2O2 might be more suited for global signaling [6,8,10–13].
Therefore, when endogenously produced at low levels during non-
pathological conditions, it is likely that primary ROS predominantly
affect closely apposed targets and signaling by these ROS should be
highly compartmentalized and local. Proper investigation of this
mechanism requires quantitative experimental techniques allowing
the local detection and manipulation of ROS and its downstream
effects in the living cell. An in-depth discussion of the mechanisms
involved in mitochondrial ROS generation and removal falls outside
the scope of this review and is presented elsewhere (e.g. [5,7,8,
14,15]). Therefore we only provide a brief overview about this subject
(Sections 2 and 3) followed by a more extensive treatment of experi-
mental strategies for live cell detection and exogenous manipulation
of cellular and mitochondrial ROS (Section 4).
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2.1. Types of ROS
The primary ROS, O2•−, is formed by the one-electron reduction of
O2. The latter readily penetrates cells because of its ability to dissolve
in the hydrocarbon core of cell membranes. In fact, O2 was classiﬁed as
a fat-soluble molecule, as demonstrated by its olive oil/water
partition coefﬁcient of 4.4 at 25 °C (see [16] and the references
therein). In mitochondria, O2•− formation is thermodynamically
favorable because the reduction potential is high in this compartment
(Eh=68 mV), even at low [O2] (i.e. 1 µM) and high [O2•−] (200 pM;
[15]). The concentration of O2•− in themitochondrial matrix generally
is kept low because of the action of manganese superoxide dismutase
(MnSOD or SOD2), which converts O2•− into hydrogen peroxide
(H2O2). The latter ROS is able to leave the mitochondrion and, when
produced in excessive amounts, can also reach the extracellular space
[6].
The hydroxyl radical (OH•) is another important member of the ROS
family, which can be formed under conditions of oxidative stress when
high concentrations of O2•− and/or H2O2 are present. In this situation,
O2•− can stimulate H2O2 formation and the release of Fe2+ from iron–
sulphur (FeS)-containing proteins like CI or the TCA cycle enzyme
aconitase. Subsequently, the generated Fe2+ andH2O2 can react to form
OH• by the Fenton reaction. The OH• radical is highly reactive, as
reﬂected by its half-life (t1/2) of approximately 10−9 s, and therefore
reacts very close to its site of formation [5]. In comparison, O2•− and
H2O2 display much larger t1/2 values of 10−6 s and 10−5 s, respectively
[12]. The range of action of each ROS is co-determined by their free
aqueous diffusion distance, which appears to have an upper limit of
0.16 µm for O2•− and 0.23–0.46 µm for H2O2 [8]. In the mitochondrion,
this distance is likely lowered by the action of ROS scavengers like
MnSOD, ROS reactivity with nearby (bio)molecules and the viscosity of
the mitochondrial matrix, which is somewhat higher than water. Also
singlet oxygen (1O2) is a member of the ROS family capable of
biomolecule oxidation. In contrast to O2•−, H2O2 and OH•, 1O2 can be
formedwhenendogenousor exogenousphotosensitizers absorb light of
the appropriate wavelength in the presence of oxygen [10]. Light-
induced 1O2 formation can artiﬁcially stimulate the oxidation of ROS-
reporting sensor molecules (Section 4.1.1) and has been used to locally
increase ROS levels (Section 4.2.1).
2.2. Origins of mitochondrial ROS
Most mitochondrial activities, including ATP generation, organelle
fusion, protein import and metabolite/ion exchange depend on a
proper proton gradient across the MIM. This gradient generates an
inward proton-motive force (PMF), which is maintained by the action
of 4 ETC complexes (CI–CIV). The PMF consists of both a potential
difference (Δψ) and a proton gradient (ΔpH), and is used by the F0F1-
ATP synthetase (CV) to convert ADP into ATP. Together, CI–CV con-
stitute the oxidative phosphorylation (OXPHOS) system. Over the
years, several OXPHOS complexes were implicated as relevant sources
of ROS. For instance, ROS levels dose-dependently increased upon
acute (10 min) and chronic (72 h) treatment with speciﬁc inhibitors
of CI (rotenone) and CIII (antimycin A) in human skin ﬁbroblasts. In
contrast, CV inhibition by oligomycin did not detectably increase ROS
levels in these cells [8].
2.2.1. Complex I
Evidence was provided that CI constitutes a major source of ROS in
healthy cells [8,14,15]. It appears that O2•− is generated at the ﬂavin
(FMN) group in the NDUFV1 subunit and/or the ubiquinone (CoQ)-
binding site of CI [8,15]. In principle, ROS can also be produced by CI
via reverse electron transfer (RET) from CII to CI. RET was observed in
isolated mitochondria respiring on the CII substrate succinate and isprevented by inhibition of CI using rotenone [17,18]. However, CI
inhibition by rotenone in living cells generally results in higher
instead of lower ROS levels [19–22]. This suggests that RET might not
signiﬁcantly contribute to mitochondrial ROS formation in healthy
cells, although this likely depends on the cell type, rotenone
concentration and incubation time [8].
2.2.2. Complex III
In addition to CI also CIII can generate mitochondrial ROS [23,24].
However, experiments in isolated nerve terminals revealed that
only very high levels of CIII inhibition (70–80%) lead to detectable
increases in H2O2 generation [19]. Similarly, only high-level inhibition
of CIV increased H2O2 levels. In contrast, a 16% inhibition of CI sufﬁced
to increase H2O2 levels, suggesting that during physiological condi-
tions CI is a more important ROS source than CIII and CIV in these cells
[14]. In human skin ﬁbroblasts, CIII inhibition with antimycin A
acutely increased ROS generation with an EC50 value of 2.9 nM [8].
Although CIII activity was not determined, this suggest that CIII might
also be a source of ROS when just slightly inhibited, implying that the
physiological relevance of CIII-mediated ROS generation is cell type
speciﬁc.
2.2.3. α-Ketoglutarate dehydrogenase
Also α-ketoglutarate dehydrogenase (α-KGDH) can signiﬁcantly
contribute to mitochondrial ROS production [1,2,14]. α-KGDH cata-
lyzes an important step of the TCA cycle, namely the conversion of α-
ketoglutarate, coenzyme A and NAD+ into succinyl-CoA, NADH and
CO2. Mammalian α-KGDH consists of three enzymes: α-ketoglutarate
dehydrogenase (E1), dihydrolipoamide succinyltransferase (E2), and
dihydrolipoamide dehydrogenase (E3 or Dld). The latter enzyme also
constitutes part of the pyruvate dehydrogenase (PDH) enzyme
complex. Evidence was provided that the E3/Dld enzyme can gener-
ate O2•−. The E3/Dld enzyme contains a ﬂavin group that normally
donates electrons to NAD+. However, when [NAD+] is low (i.e. when
the NADH/NAD+ ratio is high), electrons can be directly transferred
to O2 to form O2•−. Interestingly, α-KGDH is inhibited by its own
product succinyl-CoA, by a high NADH/NAD+ ratio and by a high
dihydrolipoate/lipoate ratio. Conversely, α-KGDH is activated by low
concentrations of ionic calcium (Ca2+) and matrix ADP [2,25]. This
suggests that the increased ROS levels that are generally observed in
rotenone-treated cells, might be (partially) due to stimulation of ROS
generation by α-KGDH via the rotenone-induced increase in mito-
chondrial NADH/NAD+ ratio.
2.2.4. Other mitochondrial ROS sources
In principle, mitochondrial ROS can also originate from several
other mitochondrial sources [8,26–29] including P66Shc, amine oxidase
and α-glycerophosphate dehydrogenase (α-GPDH). Of these, α-GPDH,
located on the outer surface of the MIM, appears to be the most impor-
tant. In mitochondria from brown adipose tissue (BAT) and Drosophila,
α-GPDH-mediated electron transport from α-glycerophosphate to
coenzyme Q is associated with ROS production (see [15] and the refer-
ences therein). However, the physiological signiﬁcance of this process
is unclear, as α-GPDH is expressed at relatively low levels in most
mammalian tissues, although it may be more important in the brain
[26].
3. Removal of mitochondrial ROS
Mitochondrial ROS can induce oxidative stress if it exceeds the
capacity of ROS detoxifying systems. Alternatively, ‘normal’ ROS
production can induce oxidative stress under conditions where the
antioxidant capacity is reduced. Within the mitochondrial matrix,
O2•− is either spontaneously dismutated into H2O2 or via a two-
electron reaction catalyzed by the tetrameric MnSOD. Using isolated
mitochondria, evidence was provided that cytochrome-c (cyt-c) can
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action of cyt-c oxidase [30,31]. In the cytosol, O2•− dismutation is
predominantly taken care of by copper–zinc-SOD (CuZnSOD or
SOD1), which presence was also demonstrated in the mitochon-
drial intermembrane space (IMS; [32]). In most mammalian cell types
H2O2 is primarily broken down by catalases (CATs), glutathione
peroxidases (GPx) and peroxiredoxins (Prx; [8,15,33]).
CAT catalyzes the conversion of 2 molecules of H2O2 into H2O and
O2 and is mainly expressed in peroxisomes, whereas mitochondria
have very low levels of this enzyme. Therefore, mitochondria appear
to be a more important cellular source of H2O2 than peroxisomes. In
the cytosol and mitochondria GPx-mediated conversion of H2O2 into
H2O is directly coupled to the oxidative formation of GSSG from
glutathione (GSH). GSH is regenerated from GSSG by the action of
glutathione reductase (GR) which requires NADPH.
Another mechanism to convert H2O2 into H2O involves the
formation of oxidated Prx, which is converted back again into reduced
Prx by the oxidation of thioredoxin-2 (TRx). The latter requires
NADPH and the action of thioredoxin reductase-2 (TRxR; [8,15]).
Although GPxI is considered to be one of the major contributors to
H2O2 removal in mitochondria, PrxIII is 30-fold more abundant in
mitochondria of HeLa cells [34]. Another Prx isoform (PrxV) is also
present in mitochondria and its overexpression protects against
oxidative damage [35]. As explained above, excessive O2•− production
can also stimulate OH• formation (for its detoxiﬁcation, see below).
OH• induces the formation of carbon-centered lipid radicals (L•) from
poly-unsaturated fatty acids (LH). These, in turn, can form lipid
peroxyl radicals (LOO•), which are readily degraded to malondialde-
hyde β-hydroxyacrolein (MDA) and 4-hydroxynonenal (4HNE).
Formation of MDA and 4HNE is counterbalanced by a cascade of
antioxidant redox reactions (for more details: see [5,8,15]).
Glutathione (GSH) is one of the most important non-enzymatic
antioxidants which further include ascorbic acid (vitamin C), α-
tocopherol (vitamin E), vitamin A and its precursor β-carotene,
carotenoids, ﬂavonoids and lipoic acid [5,36]. The ratio of GSH to GSSH
is a good determinant of the thiol redox state of the cell, and under
normal conditions reduced GSH is the more abundant form in the
cytosol, nucleus and mitochondria. Since GSH is synthesized in the
cytosol, mitochondria have to import it across the MIM [5]. GSH can
act as an antioxidant in several ways, for instance: (i) GSH is a cofactor
ofGPx (see above), (ii)GSHcandirectly neutralizeOH•, and (iii)GSHcan
regenerate vitamins C and E to their active forms [5]. In cells, the most
important vitaminic antioxidant is vitamin E, which is lipid-soluble
(octanol/water partition coefﬁcient, LogP=10.7; source: pubchem.
ncbi.nlm.nih.gov) and exists in 8 different forms (4 tocopherols and 4
tocotrienols). Of these, α-tocopherol seems to have the highest activity
in trapping lipid peroxyl radicals (LOO•) and thereby preventing the
propagation of lipid peroxidation. α-Tocopherol is present in relatively
low concentrations in mitochondria of which 22% resides in the MIM
and 78% in the mitochondrial outer membrane (MOM; [37]). In theory,
also vitamin C can react with lipid peroxyls in its ascorbate form.
However, vitamin C is hydrophilic (LogP=−1.8) and therefore unlikely
to be involved in the direct prevention of lipid peroxidation. However,
vitamin C is capable of recycling vitamin E to its reduced form [38,39].
Finally, also CoQ has been recognized as a lipid-soluble mitochondrial
antioxidant. Due to its location in theMIM, CoQ appears to primarily act
in thepreventionof lipidperoxidationbut it is also capable ofpreventing
protein oxidation. When reduced, CoQ can regenerate vitamin E
from the α-tocopheroxyl radical [40].
4. Detection and manipulation of mitochondrial ROS
4.1. Detection of mitochondrial ROS
Mitochondrial and cellular functions are intricately linked.
Therefore experimental approaches are needed that allow the analysisof ROS generation and ROS-induced signaling and/or stress in living
cells. We here discuss ﬂuorescence reporter molecules suited for live
cell studies that are compatible with epiﬂuorescence and/or confocal
laser scanning microscopy (CLSM). The focus will be mainly on
ﬂuorescent ROS probes that we have used for live cell analysis in our
laboratory but we also discuss some promising novel ROS reporters.
In principle, two types of reporter molecules can be distinguished:
(i) chemical reporter molecules, which are loaded into the cell using
speciﬁc incubation (‘loading’) protocols, (ii) proteinaceous reporter
molecules (i.e. proteins) that are introduced into the cell by stable or
transient transfection.
4.1.1. Chemical ROS reporters
4.1.1.1. Hydroethidine. O2•− is the initial ROS produced inmitochondria.
Due to the relatively small t1/2 of O2•− and its rapid conversion by SODs,
quantitative detection of O2•− is not trivial. A frequently used chemical
reporter for superoxide detection is hydroethidine (HEt) and its
mitochondria-targeted variant Mito-HEt (a.k.a. MitoSOX-red), which
consists of a HEt molecule linked to a cationic triphenylphosphonium
(TPP+) group [41]. Both HEt and Mito-HEt easily cross phospholipid
bilayers. The initial oxidation of non-ﬂuorescent HEt and Mito-HEt
appears to involve two steps: (i) generation of a radical (HE•+) and
(ii) successive oxidative formationof twopositively chargedﬂuorescent
products: ethidium (Et+) and 2-hydroxyethidium (2-HO-Et+; [42]).
Importantly, only the formation of 2-HO-Et+ is speciﬁc for O2•−. To
discriminate between Et+ and 2-OH-Et+ ﬂuorescence in living cells,
excitation/emission wavelengths of 396/580 nm (only 2-OH-Et+)
and 510/580 nm (Et+ and 2-OH-Et+) can be used [41]. Similar to
tetramethylrhodamine (TMRM) or rhodamine-123 (R123), the extent
of mitochondrial Mito-HEt accumulation depends on its extracellular
concentration, the potential difference across the plasma membrane
(ΔV) andΔψ [43]. Because of its positive charge,Mito-HEt preferentially
accumulates ∼1000 fold within the mitochondrial matrix. This accu-
mulation, together with its rapid rate of reaction with O2•−(4∙106 M−1∙
s−1) should enable Mito-HEt to compete with MnSOD for O2•− and
allow speciﬁc detection of mitochondria-generated O2•− [41]. Of note,
also 2-HO-Et+ and Et+ are cations and therefore will accumulate in the
mitochondrial matrix (see below). However, in case of HEt the origin
of its oxidation is more difﬁcult to establish than for Mito-HEt since
HO-Et+ and/or Et+ can be formed in, for instance, the cytosol and then
move to the mitochondrial matrix.
In a previous study [21], we assessed the localization and inten-
sity of HEt oxidation products in human skin ﬁbroblasts using
epiﬂuorescence microscopy. To this end, we used a protocol in
which cells were incubated with 10 µM HEt for 10 min at 37 °C to
allow HEt oxidation, followed by thoroughly washing the cells to
remove excess HEt. To measure ﬂuorescence, cells were illuminated
by 490 nm excitation light using a monochromator for 100 ms. During
this time period ﬂuorescence emission was directed by a dichroic
mirror (525DRLP) through a 565 long pass emission ﬁlter (565ALP)
onto a CoolSNAP HQ monochrome charge-coupled device (CCD)
camera. Image acquisition at 0.2 Hz did not increase the ﬂuorescence
signal for at least 10 min [21]. This indicates that excess HEt was
effectively removed, ﬂuorescent HEt oxidation products did not leak
out of the cell, and photobleaching and/or photoactivation did not
occur during this time period. Using the above approach, and con-
sidering the in vitro spectral properties of Et+ and 2-OH-Et+ [42], the
contribution of 2-OH-Et+ to the total ﬂuorescence signal is expected
to be ∼2-fold higher than that of Et+. HEt oxidation products were
detected in mitochondrial tubules and the nucleus (nucleoli; Fig. 1A).
Individual cells always displayed a higher nuclear than mitochondrial
ﬂuorescence, compatible with the increased ﬂuorescence quantum
yield upon DNA-binding of Et+ and 2-OH-Et+ [42] and/or a higher
nuclear viscosity. However, both in cells from patients with isolated
nDNA-encoded CI deﬁciency and rotenone-treated ﬁbroblasts, nuclear
Fig. 1.Quantiﬁcation of ROS, cellular lipid peroxidationand thiol redox environment inhumanskinﬁbroblasts. (A)Typical confocalﬂuorescence imageofhuman skinﬁbroblasts incubated
with 10 µM hydroethidine (HEt) for 10 min (37 °C). Fluorescence signals arise from the ROS-stimulated formation of ethidium (Et+) and/or 2-hydroxyethidium (2-HO-Et+), and
were detected in both nucleoli and a widespread network of tubular structures in the cytosolic compartment. The white box depicts a magniﬁed view of the cell markedwith an asterisk.
(B) Upon addition of the mitochondrial uncoupler carbonylcyanide-p-triﬂuoromethoxy-phenylhydrazone (FCCP; 1 µM), staining of the cytosolic tubular structures was lost and Et+/2-
HO-Et+ translocated to the nucleus. (C) Typical confocal ﬂuorescence images of a human skin ﬁbroblast pre-stained with 1 µM of 5-(and-6)-chloromethyl-2′,7′-dichlorodihydro-
ﬂuorescein diacetate (CM-H2DCFDA) for 10 min (37 °C). Fluorescence arises from the ROS-stimulated formation of CM-DCF, which occurs linearly over time. By measuring the rate of
ﬂuorescence increase at different timepoints, the level of CM-DCF-formation inducingROS canbedetermined. (D) Typical confocalﬂuorescence image of human skinﬁbroblasts incubated
with the ﬂuorescent lipid peroxidation probe C11-BODIPY581/591 (4 µM, 30 min, 37 °C). Upon oxidation, the red emitting formof the dye (590 nm) is converted into a green emitting form
(520 nm), which results in an increase in green-to-red emission ratio. (E) Typical epiﬂuorescence image of human skinﬁbroblasts expressing cytosolic roGFP1 (cyt-roGFP1), a ﬂuorescent
proteinaceous thiol redox sensor. The latter was expressed using a baculoviral transduction system. The ﬂuorescence emission ratio of roGFP1 after excitation at 400 nm (oxidized state)
and 480 nm(reduced state) is ameasure of the ambient thiol redox environment. (F) Sameas panel E but now for themitochondrialmatrix-targeted variant of roGFP1 (mit-roGFP1). Used
ﬁbroblast cell lines: #5120 (panels A,B,C); #5067 (panel E), #5170 (panel F) [76].
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[4,21]. This means that either signal can be used to quantify Et+/2-
OH-Et+ ﬂuorescence. Protonophore-induced dissipation of Δψ induced
a rapid decrease in tubularﬂuorescence and concomitant increase in the
nuclear ﬂuorescence signal, indicating translocation of Et+/2-OH-Et+
from the mitochondrial to the nuclear compartment (Fig. 1B; [4]). This
means that Et+/2-OH-Et+ are (partially) retained in the mitochondrial
matrix in a Δψ-dependent manner. Therefore it is important that
when reduced mitochondrial Et+/2-OH-Et+ signals are observed, also
Δψ is quantiﬁed in parallel experiments. An approach allowing proper
quantiﬁcation of Δψ has been described elsewhere [44].
To compare HEt and Mito-HEt, human control ﬁbroblasts were
cultured in the presence of vehicle (CT) or rotenone (R; 100 nM) for
72 h. Next, cells were incubated with 10 µM HEt or Mito-HEt for
10 min at 37 °C and images were acquired using illumination times of
100 ms and 500 ms for HEt and Mito-HEt, respectively. We used
spectral settings allowing (i) combined detection of Et+ and 2-OH-Et+
(490 nm excitation, 580 nm emission) or, (ii) more speciﬁcally 2-OH-
Et+ (405 nm excitation, 580 emission) (Fig. 2). Cells stained with HEt
or Mito-HEt displayed ﬂuorescence signals in cytosolic tubular struc-
tures (i.e. mitochondria) as well as in the nucleoli (Fig. 2A). Fluores-
cence signals obtained with 405 nm excitation were much lower
(i.e. closer to the background signal) thanwith 490 nm excitation. This
suggests that the extent of O2•−-speciﬁc 2-OH-Et+ formation is over-
estimated when 490 nm excitation is used. Analysis of a large quantityof cells from multiple experiments revealed an identical rotenone-
induced ﬂuorescence increase (to ∼220% of CT) for 405 and 490 nm
excitation in HEt-stained cells (Fig. 2B; left panel). In case of Mito-HEt,
the rotenone-induced ﬂuorescence increase was less (to ∼140–175%
of CT) than for HEt and signiﬁcantly lower (p<0.001) for 405 nm
excitation than for 490 nm (Fig. 2B; right panel). These results support
our above conclusion that a large fraction (∼50%) of HEt-detectable
ROS in rotenone-treatedﬁbroblasts (using 490 nmexcitation) consists
of O2•− originating from mitochondria.
4.1.1.2. CM-H2DCFDA. The oxidative conversion of non-ﬂuorescent
2′,7′-dichlorodihydroﬂuorescein (H2DCF) into ﬂuorescent 2′,7′-
dichloroﬂuorescein (DCF) has been widely applied to measure
oxidant levels in living cells. This compound is typically loaded into
cells in the form of amembrane-permeant diacetate (DA) ester, which
is converted into a membrane impermeant product inside the cell.
Still, DCF has been shown to be prone to passive leakage across the
plasma membrane which limits the duration of cell observation after
loading. Therefore, a DCF variant with chloromethyl groups (CM-
H2DCF) was developed with greatly reduced passive dye leakage (see
[45] and the references therein). By attaching esterase-cleavable DA
groups to CM-H2DCF its membrane-permeability was improved. The
resulting 5-(and-6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein
diacetate (CM-H2DCFDA) is rapidly taken up by cells. Intracellularly,
it is converted into non-ﬂuorescent CM-H2DCF by esterase action and
Fig. 2. Comparison of the ﬂuorescence signals of hydroethine (HEt) and mitochondria-targeted HEt (Mito-HEt) in human skin ﬁbroblasts. (A) Typical epiﬂuorescence images of
human skin ﬁbroblasts stained with HEt or Mito-HEt. Fluorescence arises from the ROS-stimulated formation of ethidium (Et+) and/or 2-hydroxyethidium (2-HO-Et+) and images
were acquired to allow combined detection of Et+ and 2-OH-Et+ (490 nm excitation) or preferentially 2-OH-Et+ (405 nm excitation). Individual images in this panel were linearly
contrast-stretched for visualization purposes. (B) Effect of rotenone (R) treatment (100 nM, 72 h) on ﬂuorescence signals in cells stained with HEt (left panel) or Mito-HEt (right
panel). In this ﬁgure, signiﬁcant differences between vehicle-control (CT) and rotenone-treated cells are marked by *** (p<0.001), error bars indicate standard-error of the mean
and numerals reﬂect the number of cells analyzed in at least two independent experiments. Used ﬁbroblast cell line: #5120.
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cent CM-DCF. The levels of CM-DCF-forming ROS can be reliably
determined by measuring the rate of CM-DCF formation (see Fig. 1C;
[45,46] and the explanation below).
In human skin ﬁbroblasts acute application of H2O2 stimulated
CM-DCF formation [45–47]. Interestingly, H2O2 but also O2•−, Fe(III),
GPx and cyt-c were unable to stimulate ﬂuorescent DCF formation
from H2DCF in a cell free system [48]. In contrast, when horseradish
peroxidase, Fe(II), CAT, CuZnSOD, xanthine oxidase, ONOO−, or nitric
oxide were present DCF formation was stimulated [48–50]. Together,
these results are compatible with the idea that intact cells contain
catalysts, like transition metal ions, heme peroxidases, and/or
CuZnSOD that enable the H2O2-induced formation of CM-DCF. In this
respect, evidence was provided that H2O2 stimulates CM-DCF forma-
tion through a peroxide-catalyzed reaction [51]. Froma chemical point
of view, itwasproposed that the reactionmechanism for the formation
of CM-DCF from CM-H2DCF involves two main steps [52]: (i) conver-
sion of CM-H2DCF into CM-DCFH•/CM-DCF•− stimulated by CO3•−,
NO2• and/or peroxidase-like catalysts involving conversion of GS• into
GSH, (ii) formation of CM-DCF stimulated by generation of O2•−
from O2. The mechanism also involves three other (side) reactions:
(iii) conversion of CM-DCF into a phenoxyl radical (CM-DCF-O•)
stimulated by CO3•−, NO2• and/or peroxidase-like catalysts, (iv) light-
induced formation of ‘DCF*’ and (v) back-conversion of DCF* into CM-
DCFH•/CM-DCF•− from CM-DCF paralleled by formation of GS• from
GSH. Reactions iv and v are compatible with the observation that
laser light can stimulate CM-DCF formation (see [45] and references
therein). In this sense, evidence has been provided that photo-
oxidation of CM-DCF is stimulated by 1O2 generated upon irradiation
with laser light with λ>300 nm [53]. However, 1O2 is unable to
directly enhance CM-DCF formation but induces formation of CM-
DCFH•/CM-DCF•−, possibly via reactions iv and v in the above mecha-
nism. Next, CM-DCFH•/CM-DCF•− is then converted into CM-DCF
(reaction i) paralleled by formation of O2•−.
Our ﬁndings in human skin ﬁbroblasts show that the relative
contribution of the photo-oxidation process is minimal at the lowest
practical laser intensity of 34 µW(488 nm,measured at the aperture of
the objective). Tomaximize the sensitivity of ﬂuorescence detection at
this low laser intensity, we used a 500 nm long pass (LP) instead of
a band-pass emission ﬁlter. Furthermore, we applied optimal blacklevel and brightness settings, whereas the signal-to-noise ratio was
improved by real time image averaging [45]. We further observed that
when the above imaging approach was used, CM-DCF ﬂuorescence
increased linearly with time during maximally 200 s. This means that
during this time the oxidative conversion of CM-H2DCF to CM-DCF
proceeds according to a zero-order reaction, given by: [CM-DCF](t)=
VCM-DCF∙t+[CM-DCF]0 with [CM-DCF](t) being the recorded CM-DCF
ﬂuorescence signal, VCM-DCF being the rate ofﬂuorescence increase and
[CM-DCF]0 being the CM-DCF ﬂuorescence signal at the beginning of
the recording (t=0). From this equation, it follows that VCM-DCF is
independent of [CM-H2DCF] and therefore solely determined by the
steady-state oxidant level [45]. The zero-order model predicts that
VCM-DCF increases as a function of [CM-DCF]0. Indeed, VCM-DCF changed
proportionally with [CM-DCF]0 in ﬁbroblasts from healthy volunteers
and from patients with isolated CI deﬁciency [45]. Also in the presence
of H2O2, VCM-DCF and [CM-DCF]0 increased to the same extent. Beyond
a measuring time of 200 s, however, the increase in CM-DCF
ﬂuorescence became supralinear. This may suggest that CM-DCF,
once formed in sufﬁcient quantities, stimulates the conversion of
CM-H2DCF into CM-DCF. Alternatively, cellular oxidant levels might
increase upon prolonged laser illumination, thereby accelerating the
formation of CM-DCF. Our results demonstrate that normalization of
the CM-DCF time trace (i.e. dividing by [CM-DCF]0) is not appropriate,
since this would lead to underestimation of VCM-DCF at higher [CM-
DCF]0.
The lack of speciﬁcity of CM-DCF formation makes it difﬁcult to
identify the nature of the oxidants detected by the probe [52,54].
Therefore, the formation of CM-DCF in cellular systems can best be
considered as a marker of cellular oxidant levels rather than as a direct
reporter of a speciﬁc ROS/RNS species [45]. In human skin ﬁbroblasts,
rotenone-treatment readily increased the rate of Et+/2-OH-Et+
formation without affecting the rate of CM-DCF formation [4],
suggesting that the formation of Et+/2-OH-Et+ and CM-DCF is
stimulated by different types of ROS and/or in different cellular
compartments. The latter is compatible with the fact that CM-H2DCF
has a very low reactivity towards O2•− [52].
4.1.1.3. Dihydrorhodamine 123. Dihydrorhodamine 123 (DHR123) is a
reduced rhodamine that is unreactive towards O2•− and H2O2 in the
absence of catalysts [52]. Fluorescent R123 is directly formed in the
1039M. Forkink et al. / Biochimica et Biophysica Acta 1797 (2010) 1034–1044presence of OH•, CO3•−, NO2•, hypochlorous acid (HClO), ONOO−, Fe2+
and cyt-c [52,55]. In this respect, also DHR123 constitutes a marker of
overall oxidant levels. In cells, formation of R123 can be monitored
using 488 nm excitation light and emission detection >500 nm [21].
Given the cationic nature of R123, it is important to also quantifyΔψ in
parallel experiments (see above) when a reduced cellular R123
staining is encountered.
4.1.1.4. C11-BODIPY581/591. An indirect means to measure mitochon-
drial ROS production in living cells is through assessing the extent of
lipid peroxidation. A suitable reporter molecule for this purpose is the
fatty acid analogue C11-BODIPY581/591 (Fig. 1D) which is insensitive
to O2•−, nitric oxide and hydroperoxides [56]. Upon oxidation, the red
emitting reduced form of the dye (595 nm) is converted into a green
emitting oxidized form (520 nm), which results in an increase in
green-to-red emission ratio [57]. We have quantiﬁed lipid peroxida-
tion in human skin ﬁbroblasts by confocal microscopy using an excita-Fig. 3. Properties of the lipid peroxidation sensor C11-BODIPY581/591 in human skin ﬁbrob
photobleaching (FRAP) analysis using confocal microscopy. A FRAP and background (B) regio
measured over time for the red and green emitting forms of C11-BODIPY581/591. (B) Oxidation
the red emitting form of the dye (590 nm) and an increase in ﬂuorescence of the gree
photobleaching) kinetics for the green form of C11-BODIPY581/591 were similar and yielded a
and FLIP signals were ﬁtted using amono-exponential model (Y=Y0+A1∙e− t/Tmono). (C)Wh
emission ratio was increased, indicative of lipid peroxidation. In this ﬁgure, signiﬁcant differ
bars indicate standard-error of the mean and numerals reﬂect the number of cells analyzedtion wavelength of 488 nm, a 560DM dichroic mirror and appropriate
band-pass ﬁlters (535D20 and 580LP; [21]). Upon treatment with
rotenone, the green/red C11-BODIPY581/591 emission ratio increased
2-fold. However, in the presence of the mitochondria-targeted MIM-
embedded antioxidant MitoQ (see Section 4.1.2), rotenone was
unable to stimulate C11-BODIPY581/591 oxidation. These data demon-
strate that lipid peroxidation is stimulated by rotenone and that
this effect is completely blocked by MitoQ. Fluorescence recovery
after photobleaching (FRAP; [58]) analysis revealed that the laser
bleach pulse (488 nm) increased the level of oxidized (green) C11-
BODIPY581/591 (Fig. 3A). This suggests that high-intensity laser illumi-
nation induces oxidation of C11-BODIPY581/591 and/or membrane
lipids. Next, the FRAP dynamics of the red emitting form and the FLIP
(ﬂuorescence loss in photobleaching) dynamics of the green emitting
form in a region of interest (ROI) distal to the FRAP region were
analyzed (Fig. 3B). This revealed a similar (slow) mobility for the red-
and green-emitting forms of C11-BODIPY581/591 compatible with theirlasts. (A) Analysis of the mobility of C11-BODIPY581/591 by ﬂuorescence recovery after
n of interest (ROI) were deﬁned in the pre-bleach image and ﬂuorescence recovery was
of C11-BODIPY581/591 by the laser bleach pulse resulted in a reduction in ﬂuorescence of
n emitting form (520 nm). FRAP kinetics for the red and FLIP (ﬂuorescence loss in
time constant in the range of minutes, compatible with its membrane localization. FRAP
en cells were treatedwith hydrogen peroxide (H2O2), the C11-BODIPY581/591 green/red
ences between vehicle- (CT) and H2O2-treated cells are marked by *** (p<0.001), error
in at least two independent experiments. Used ﬁbroblast cell line: #5120 [76].
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peroxide (H2O2), the C11-BODIPY581/591 green/red emission ratio
was increased, indicative of lipid peroxidation (Fig. 3C).
4.1.2. Proteinaceous ROS reporters
Protein-based ROS reporter molecules have the distinct advantage
that they can be selectively expressed in different cell compartments
(e.g. nucleus, ER lumen, mitochondrial matrix, MIM, MOM, golgi lumen,
golgimembrane, plasmamembrane)byN-orC-terminally fusing themto
speciﬁc targeting sequences [59]. For mitochondrial matrix expression,
theN-terminal targeting sequenceof subunitVIII of cytochrome-coxidase
(Cox8) is frequently used (MSVLTPLLLRGLTGSARRLPVPRAKIHSLGDP).
For several reporter molecules, 2–3 subsequent Cox8 targeting se-
quences are needed to ensure proper targeting and efﬁcient expres-
sion [59–61]. In addition to targeting sequences, proteinaceous
reporters can also be fused to speciﬁc ROS generating or ROSdetoxifying
proteins of interest allowing local detection. In the latter case, it should
be investigated whether steric hindrance or folding interference
between the protein and the reporter molecule is present. To minimize
the chance of steric hindrance, a linker between the protein of interest
and reportermolecule is generally used. Such a linker should beﬂexible,
soluble, resistant to proteolysis and display no secondary structure or
aggregation [62]. In this respect, Miyawaki et al. constructed a series of
DNA plasmids that facilitate the fusion of coding sequences for any two
protein domains with a DNA linker that encodes a triple repeat of the
amino-acid linkerGly-Gly-Gly-Gly-Ser (i.e. [(GGGGS)3]; [63]). Belowwe
discuss protein-based reporters for detection of O2•−, H2O2 and thiol
redox status.
4.1.2.1. cpYFP. Recently, a circularly permuted YFP (cpYFP), previously
used as a core component of the ratiometric Ca2+ indicator Pericam
[64], was presented as a speciﬁc reporter of O2•− [65]. In this study,
cpYFP was targeted to the mitochondrial matrix (mt-cpYFP) using
the cytochrome-c oxidase subunit IV (Cox4) targeting sequence with
the aim to measure O2•− in this compartment. Interestingly, it was
observed that the mt-cpYFP ﬂuorescence signal displays transient all
or none ‘ﬂashes’. However, in a recent comment several points of
concern have been raised regarding the O2•−-speciﬁcity of cpYFP [66],
the most important being that the total removal of O2 did not com-
pletely abolish mt-cpYFP ﬂashes. Moreover, mt-cpYFP ﬂashes were
absent in the presence of the CIII-inhibitor antimycin A, which is
demonstrated to stimulate O2•−-generation in many different experi-
mental systems. It was proposed that the changes in mt-cpYFP ﬂashes
observed in the various experiments might reﬂect changes in ATP
levels, rather thanO2•−, and as such are linked to the energization state
of mitochondria [66]. The latter explanation might relate to previous
ﬁndings, revealing that ﬂuctuations in free or Mg2+-bound ATP can
affect the signal output of CFP-YFP-based FRET sensors [67]. In this
respect it is interesting to note that the HyPer H2O2 sensor (see next
section), which contains cpYFP, is insensitive to O2•−. Importantly, the
ﬂuorescence ratio of cpYFP and Hyper is also pH-dependent. This
dependency is similar to that reported for ratiometric Pericam, which
exhibited pH-induced changes in ﬂuorescence ratio between pH 6 and
pH 10 [64]. Therefore measurements with cpYFP or HyPer should be
accompanied by parallel pH quantiﬁcation [68]. The latter could
be carried out using chemical reporters in the cytosol (e.g. BCECF,
SNARF-1) or mitochondria-targeted protein-based pH sensors like
‘pHluorins’ [69] or ‘pHlameleons’ [70]. Taken together, it appears that
more experimental data is required to determine the value of cpYFP as
a speciﬁc O2•−-sensor.
4.1.2.2. HyPer. HyPer is a ﬂuorescent ratiometric ROS sensor in which a
cpYFP is inserted into the regulatory domain of the E. coli transcription
regulator OxyR [68]. OxyR contains an H2O2-sensitive domain (amino
acids 80–310) and a DNA-binding domain (amino acids 1–79). Upon
oxidation by H2O2, the reduced form of OxyR is converted into anoxidized DNA-binding form. As a result, dramatic conformational
changes occur in the regulatory domain of OxyR [71]. HyPer was
generated by inserting cpYFP between residues 205 and 206 of
the OxyR regulatory domain. Importantly, cpYFP ﬂuorescence was
demonstrated to be very sensitive to conformational changes of an
attached protein [64]. HyPer displays two excitation peaks at 420 nm
(reduced form) and 500 nm (oxidized form) and a single emission
peak at 516 nm. Upon H2O2 application, the HyPer ﬂuorescence emis-
sion following 420 and 500 nm excitation decreases and increases,
respectively. HyPer was rapidly oxidized by submicromolar [H2O2]
even in highly reducing intracellular environments [71]. Quantita-
tively, the minimal [H2O2] required to induce a detectable change in
HyPer ﬂuorescence in mammalian cells was ∼5 µM. Importantly,
HyPerwas demonstrated to be speciﬁc for H2O2 and did not react with
O2•−, GSSG, nitric oxide, and ONOO− [68], allowing the use of the 500/
420 HyPer signal ratio as a measure of [H2O2]. As argued in the
previous section, HyPer is also pH-sensitive and therefore its use
should be accompanied by pH measurements. When targeted to mito-
chondria (mt-HyPer), local bursts in mt-HyPer ratio were observed
during Δψ oscillations in apoptotic HeLa cells [68]. Interestingly, the
latter study revealed that H2O2 production can be conﬁned to single
depolarized mitochondria. This is compatible with the calculated small
range of action of this ROS [8] and was proposed to be due to the
fast dilution of mitochondria-generated H2O2 in the cytosol and/or the
action of cytosolic CAT [68]. HyPer was also applied to quantify insulin-
induced H2O2 generation in myotubes [72], EGF-induced H2O2 genera-
tion in HeLa cells [71], mitochondrial H2O2 production in coronary
arterial epithelial cells [73] and H2O2-levels in zebra ﬁsh [74].
4.1.2.3. roGFPs. Reduction–oxidation-sensitive GFPs (roGFPs) have
been generated by substitution of surface-exposed residues of GFP
with cysteines in appropriate positions to form disulﬁde bonds [75].
RoGFPs display two ﬂuorescent excitation maxima whose relative
amplitudes depend on the state of oxidation. In cells, the reduced and
oxidized forms of roGFP1 are speciﬁcally excited at 480 and 400 nm
respectively. Fluorescence emission of both roGFP1 forms is detected
at 530 nm. This means that the 400/480 ratio of roGFP1 can be used as
a measure of roGFP1 oxidation status. In our research [76] we used
cytosolic (Fig 1E; cyt-roGFP1) and mitochondria-targeted variants
(Fig. 1F; mt-roGFP1) of roGFP1 (i.e. GFP with mutations C48S, S147C
and Q204C; [77]). Both roGFP1 variants were introduced into human
skin ﬁbroblasts by means of baculoviral transfection. To visualize
roGFP1-expressing cells we used a similar epiﬂuorescence system as
for HEt (see above), with alternating 300 ms excitation at 400 and
480 nm using a monochromator. Fluorescence was detected by
guiding the emission light via a dichroic mirror (525DRLP) through
a 535 band-pass ﬁlter (535DF25) onto the CCD camera. Quantiﬁcation
of cyt-roGFP1 and mt-roGFP1 signals is illustrated in Fig. 4.
In cyt-roGFP1-transfected cells (Fig. 4A), ﬂuorescence in the cytosol
(continuous ROIs), nucleus (dotted ROIs) and background ﬂuorescence
(ROI marked ‘B’) were quantiﬁed for both wavelengths. The back-
ground-corrected individual wavelength signals of roGFP1 (Fig. 4B)
were used to calculate the roGFP1 ratio for the different ROIs as a
function of time (Fig. 4C). To establish the extent of roGFP1 oxidation,
ratios were calibrated by successive addition of 1 mM hydrogen
peroxide (H2O2) and 10 mM dithiothreitol (DTT) to fully oxidize
(100% oxidation) and reduce (0% oxidation) the probe, respectively
[75,76]. H2O2 gradually increased the ﬂuorescence emission ratio to
a maximum reached within 350 s, whereas subsequent addition of
DTT rapidly reduced this ratio to below pre-H2O2 levels. Higher con-
centrations of H2O2 and DTT caused no further change in ﬂuorescence
emission ratio, indicating that the probe was maximally oxidized and
reduced, respectively [76]. A similar analysis was carried out with mt-
roGFP1 (Fig. 4D–F). No difference was observed between the roGFP1
oxidation status in the nucleus and cytosol of resting cells. However,
comparison of Fig. 4C and F reveals that the extent of roGFP1 oxidation
Fig. 4. Use of the proteinaceous thiol redox sensor roGFP1 in human skin ﬁbroblasts. (A) Fluorescence image (400 nm excitation) of a ﬁbroblast transiently expressing the cytosolic
variant of roGFP1 (cyt-roGFP1). Circles represent regions of interest (ROIs) used for quantitative measurement of thiol redox state in cell 1 (nucleus: ROI1, cytosol: ROI2) and cell 2
(nucleus: ROI2, cytosol: ROI1, ROI3) and an extracellular region used for background correction (B). Color coding corresponds to the traces in panels B and C. (B) Background-
corrected ﬂuorescence signals of the oxidized (400 nm excitation, continuous lines) and reduced forms (480 nm excitation, dotted lines) of cyt-roGFP1 for the ROIs in panel A. The
thiol redox status of roGFP1was calibrated using 1 mMH2O2 (fully oxidized) and 10 mMDTT (fully reduced). (C) Cyt-roGFP ratio signal (400/480 nm) calculated from the individual
signals in panel B. Images depict the color-coded cyt-roGFP1 ratio in resting cells (scale to the right) and in the fully oxidized and reduced state. (D) Similar to panel A but now for the
mitochondria-targeted variant of roGFP1 (mit-roGFP1). (E) Average background-corrected mitochondrial ﬂuorescence signals of the oxidized (400 nm excitation, continuous
lines) and reduced forms (480 nm excitation, dotted lines) of mit-roGFP1 for all mitochondria in panel D. A binary mask (BIN) was calculated for each image in the time-sequence
(the inset shows the BIN image at T=0 s) to determine mitochondrial ﬂuorescence signals. (F) Similar to panel C but now for mit-roGFP1. Of note, mit-roGFP1 is more oxidized than
cyt-roGFP1. Used ﬁbroblast cell line: #223V [76].
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human skin ﬁbroblasts [76]. In agreement with previous ﬁndings in
HeLa cells [75] the results in Fig. 4 demonstrate that mt-roGFP1 is
initially neither fully oxidized nor fully reduced in the mitochondrial
matrix of human skin ﬁbroblasts. This means that the redox potential of
these mitochondria lies within the effective range of roGFP1, allowing
studies of redox changes in these cells.
4.2. Manipulation of mitochondrial ROS
Until recently, mitochondrial ROS were mostly associated with oxi-
dative damage and pathology. However, evidence is accumulating that
they can also function as regulatory molecules thus playing an impor-
tant role in normal cell and organismal physiology. As already men-
tioned in the introduction, cellular ROS-induced damage and -signaling
has often been studied using exogenous ROS generating systems that
increase ROS throughout the cell (‘global’ ROS). However, given the
physicochemical properties of the various ROS, it is likely that different
ROS have a different range of action thatmight be limited to a small sub-
cellular volume surrounding the site of its generation (‘local’ ROS; see
also the section about HyPer above). Gaining a proper understanding of
ROS-induced damage and -signaling therefore requires techniques that
allow(combined) local detection of ROS (see previous section) and localmanipulation of ROS. The amount of (local) ROS in a cell depends on the
balance between: (i) its generation and (ii) its removal by antioxidants.
Experimental approaches to manipulate this balance are described
below.
4.2.1. Targeted pro-oxidants
4.2.1.1. Proteinaceous pro-oxidants. In principle, a genetically-encoded
photosensitizer should be suited to generate ROS in different cellular
compartments including mitochondria. The ﬁrst example of such a
photosensitizer is a red ﬂuorescent protein derived from the non-
ﬂuorescent and non-phototoxic chromoprotein anm2CP20 in hydrozoa
jellyﬁsh [78]. This modiﬁed protein, called KillerRed (KR), can be
visualized in living cells using low-intensity excitation at 515–560 nm
and emission detection at 555–700 nm [79]. High intensity illumination
of KR at 515–560 nm will then result in photoactivation and ROS
generation. Expression of KR in different mitochondria and cell com-
partments might be suited for studying the effects of (local) ROS
generation at speciﬁc cell locations. Obviously, this is only feasible after
careful investigation of possible side-effects of KR-activation (e.g. lipid
peroxidation) and optimization of the KR photoactivation protocol. In
comparison to enhanced green ﬂuorescent protein (EGFP), KR photo-
toxicity is at least 1000-fold higher and its light-inducedROS production
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KR-attached protein. This might for instance be applied to inactivate
proteins involved in ROS homeostasis (e.g. SODs), provided that
endogenous non-FP-labeled SODs can be largely exchanged by their
over-expressed FP-coupled counterparts. Proper mitochondrial target-
ing of KR requires the presence of two mitochondrial targeting se-
quences. Unfortunately, KR forms dimers that might affect the function
of KR-fused proteins. The latter can possibly be overcome by using a
tandem version leading to internal dimerization of KR [79].
4.2.1.2. Cell penetrating peptides. Cell penetrating peptides (CPPs)
can cross the plasma membrane and thereby introduce cargo like pro-
teins, nucleic acids, small molecule therapeutics and ﬂuorescent
quantum dots into the cell [80]. Part of the CPPs are also mitochondria-
penetrating peptides (MPPs) because they speciﬁcally accumulate in
mitochondria [81]. Similar to TPP+-linked compounds (see Section4.2.2)
currently identiﬁed MPPs have both cationic and lipophilic properties,
which facilitate permeation of the MIM and mitochondrial targeting.
MPPs enter the cell via a direct uptake mode thereby bypassing
endocytosis and avoiding endosomal/lysosomal sequestration [81,82].
MPPs are able to deliver negatively charged and zwitterionic small
molecules, but do require a certain level of lipophilicity of the cargo. A
member of the MMP family, TO-FrFK, was used to study oxidative stress
responses triggered by mitochondria-generated ROS in living HeLa and
MRC-5 cells. TO-FrFK contains a thiazole orange (TO) moiety, which
generates 1O2 upon photoactivation [83].
4.2.2. Targeted antioxidants
The levels, localization and/or activities of cellular antioxidants
are essential in determining which biological responses are initiated
by ROS [6,12,84]. Given the importance of oxidative stress due to
mitochondria-generated ROS during pathological conditions, consid-
erable effort has been put into the development of proteinaceous and
chemical compounds that reduce ROS levels and/or prevent ROS-
induced damage. Use of these compounds allows site-speciﬁc
blocking of (the effects of) mitochondrial ROS, but also scavenging
of speciﬁc types of ROS in, for instance, rotenone- and vehicle-treated
control cells [21,85]. Below we discuss some of these compounds in
more detail.
4.2.2.1. Proteinaceous antioxidants. To speciﬁcally reduce mitochon-
drial O2•− and H2O2 levels, overexpression of the mitochondrial SOD
(MnSOD) and mt-CAT has been performed [86,87]. Also CuZnSOD,
that normally resides in the cytosol and the mitochondrial intermem-
brane space, was expressed in the mitochondrial matrix by fusing it to
a mitochondrial targeting sequence [86].
4.2.2.2. TPP+-linked chemical antioxidants. In analogy to mito-HEt
(Section 4.1.1.1) and applying a concept pioneered by Skulachev et al.
to investigate Δψ (e.g. [88,89]), antioxidant moieties such as CoQ or
vitamin E can be targeted to the mitochondrial matrix by conjugating
them to lipophilic cations like TPP+ via an alkyl chain (see [85,90]
and the references therein). A series of mitochondria-targeted anti-
oxidants was developed to selectively decrease O2•−(MitoSOD), H2O2
(MitoPeroxidase), Fe2+ (MitoTEMPOL) and lipid peroxidation
(MitoQ10 and MitoE2). The ﬁrst TPP+-linked compound contained
the antioxidant moiety ofα-tocopherol (MitoE2). Here the subscript 2
indicates that the linking alkyl chain has a length of 2 carbon atoms.
Structurally, MitoE2 strongly resembles a TPP+-coupled form of
Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid),
which is a water-soluble antioxidant derived from α-tocopherol.
MitoE2 provedmore effective than its non-targetedvariant in preventing
peroxidation of mitochondrial lipids [85].
The TPP+-linked form of CoQ (MitoQ10) is reduced by CII, but not
CI, into its active ubiquinol form. This regeneration makes MitoQ10 a
far better antioxidant than MitoE2. Because MitoQ is almost entirelyadsorbed into the matrix face of the inner membrane, it can prevent
lipid peroxidation as was shown in isolated mitochondria. In agree-
ment with this ﬁnding, MitoQ10 fully prevented the rotenone-induced
increase in C11-BODIPY581/591 oxidation (i.e. lipid peroxidation)
without affecting the rotenone-induced increase in HEt oxidation
[21].
In an effort to generate stronger antioxidants, plastoquinone (a
chloroplast ubiquinone)was coupled to TPP+ [91].When compared to
CoQ, plastoquinone has methyl groups instead of methoxy groups,
whereas the methyl group of CoQ is replaced by a hydrogen atom.
Based upon its membrane-permeability, plastoquinonyl-decyl-TPP+
(a.k.a. SkQ1) was selected for further research. It was reported that
[SkQ1] acted as an antioxidant between 25 and 800 nM, whereas at
higher concentrations it displayed pro-oxidant properties. In compar-
ison, this range was estimated between 300 and 500 nM for MitoQ10.
The antioxidant activity of SkQ1 was regenerated in the mitochon-
drion and it effectively prevented peroxidation of the mitochondrial
lipid cardiolipin and ROS-induced apoptosis.
4.2.2.3. Mitochondria-targeted peptides. Given their cationic nature,
MitoE2, MitoQ10, SkQ1 and all other TPP+-based antioxidants are
taken up by mitochondria in a Δψ-dependent manner. This makes
them likely less efﬁcient under conditions of (highly) depolarized Δψ.
Interestingly, a novel class of cell-permeable small peptides (‘SS-
peptides’) with intrinsic antioxidant properties were designed, that
were taken up by mitochondria in a manner that was largely Δψ-
independent [92,93]. SS-peptides are water-soluble, stable in aqueous
solution, designed to resist degradation by peptidases and consist
of an alternating aromatic-cationic motif with basic amino acids
like arginine and lysine. SS-02 (i.e. Dmt-D-Arg-Phe-Lys-NH2; Dmt=
2′,6′-dimethyltyrosine) and SS-31 (D-Arg-Dmt-Lys-Phe-NH2) were
demonstrated to localize to the MIM. Although the reason for this
mitochondrial targeting is currently unknown, there might be an
electrostatic interaction between the cationic peptides and the
anionic MIM lipid cardiolipin. Replacement of the tyrosine residue
by a phenylanaline eliminated the H2O2, OH• and ONOO− scavenging
activities of the SS peptide, suggesting that the phenolic tyrosine group
mediates antioxidant activity. In this respect, it is already known
that dimethyltyrosine is a potent scavenger of oxyradicals. It is thought
that SS-02 and SS-31 prevent lipid peroxidation by scavenging of OH•
[92,93].
Another approach to speciﬁcally deliver molecules to the mito-
chondria involves the use of the antibacterial membrane disruptor,
gramicidin S (GS). Given the similarities between bacterial mem-
branes and the MIM, it might be possible to re-engineer GS in such a
way that it becomes a mitochondria-targeting moiety to which ‘cargo’
compound can be attached. This is illustrated by the molecule ‘XJV-5-
131’ [94], which contains: (i) as cargo a ROS scavenger like the stable
nitroxide radical TEMPOL, and (ii) as mitochondrial targetingmoiety a
portion of the membrane-active portion of GS. TEMPOL undergoes
redox recycling, oxidizes free iron thereby preventing Fenton reac-
tions, and also exhibits SOD-mimetic activity [90,94]. Unfortunately,
GS-based compounds can also interfere with natural redox defense
mechanisms and mitochondrial respiration by reacting with antiox-
idants and MitoQ [95].
5. Conclusion
There is still much controversy about how different mitochondrial
ROS generating systems contribute to mitochondrial/cellular ROS
levels, redox signaling and oxidative damage during healthy and
pathological conditions. This arises from the fact that a large amount
of model systems (e.g. isolated proteins, individual mitochondria and
intact primary or cancer cells) and experimental approaches (e.g.
metabolic conditions, used OXPHOS inhibitors, different ways to
stimulate ROS production, different reporter molecules) have been
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mitochondrial physiology, in combination with the central role of
these organelles in cellular survival, requires a genesis between data
obtainedwith isolatedmitochondria and living cells. Largely basedupon
our own practical experience, we here reviewed: (i) ﬂuorescence
microscopy techniques allowing assessment of (speciﬁc) ROS and/or its
downstream consequences at the cellular and mitochondrial level, and
(ii) approaches for manipulation of (speciﬁc) ROS and/or its down-
stream consequences. Proper analysis of ROS homeostasis in living cells
requires the combined use of multiple ROS reporter molecules in
parallel experiments, assessment of non-ROS-related parameters that
can induce artifacts (e.g. Δψ, pH) and inclusion of conditions known to
affect mitochondrial ROS generation as positive and negative controls
(e.g. OXPHOS inhibitors, mitochondrial uncoupling, O2 depletion). To
differentiate between local (mitochondrial) and global (cellular) ROS
effects, results obtained with local manipulations have to be compared
with those obtained using ROS generating systems and non-targeted
antioxidants that affect cellular ROS levels.
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